The FDA has actually signified a significant suppression on business mass-marketing unlawful imitator medicines, consisted of worsened variations of preferred GLP-1 medicines. This might profit Novo Nordisk, claims a United States scientist.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/us-researcher-fda-crackdown-on-illegal-copycat-drugs-to-hit-compounders/